Table 1 Characteristics of studies used for analysis
Study | year | T | N | Age | Gender | Criteria | Duration |
|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Mean(SD) | (% female) | Â | Â |
Anglin et al | 2013 | IF | 8 | Â | Â | Weight | 6 weeks |
| Â | Â | CR | 8 | Â | Â | Weight | 6 weeks |
Schübe et al | 2018 | IF | 49 | 49.4 ± 9.0 | 48.98 | Glucose, Insulin, TC, TG, LDL-C | 12 weeks |
|  |  | CR | 49 | 50.5 ± 8.0 | 48.98 | Glucose, Insulin, TC, TG, LDL-C | 12 weeks |
Pinto et al | 2019 | IF | 21 | 50 ± 12 | 71.43 | Weight, BMI, Waist, Glucose, Insulin, TC, SBP, DBP | 4 weeks |
|  |  | CR | 22 | 56 ± 8 | 72.73 | Weight, BMI, Waist, Glucose, Insulin, TC, SBP, DBP | 4 weeks |
Beaulieu et al | 2019 | IF | 12 | 34 ± 10 |  | Weight, Fat mass, BMI, Waist, Hip circumference | 12 weeks |
|  |  | CR | 18 | 35 ± 9 |  | Weight, Fat mass, BMI, Waist, Hip circumference | 12 weeks |
Kundurac et al | 2020 | IF | 32 | 47.44 ± 2.17 | 50 | Weight, Fat mass, BMI, W, Glucose, Insulin, TC, TG, LDL-C, SBP, DBP | 12 weeks |
|  |  | CR | 33 | 48.76 ± 2.13 | 54.55 | Weight, Fat mass, BMI, W, Glucose, Insulin, TC, TG, LDL-C, SBP, DBP | 12 weeks |
Kang et al | 2022 | IF | 42 | 34.7 ± 9.8 | 78.57 | Weight, Fat mass | 12 weeks |
|  |  | CR | 41 | 37.5 ± 11.7 | 87.80 | Weight, Fat mass | 12 weeks |
Hooshiar et al | 2023 | IF | 23 | 35.09 ± 8.38 |  | Weight, BMI | 8 weeks |
|  |  | CR | 24 | 36.08 ± 8.58 |  | Weight, BMI | 8 weeks |
Lin et al | 2023 | IF | 30 | 44 ± 12 | 83.33 | Weight, Fat mass, BMI, W, Glucose, Insulin, TC, TG, LDL-C, SBP, DBP | 12 months |
|  |  | CR | 30 | 44 ± 9 | 80 | Weight, Fat mass, BMI, W, Glucose, Insulin, TC, TG, LDL-C, SBP, DBP | 12 months |
Xiao et al | 2023 | IF | 85 | 57 ± 10 | 42.35 | Weight, Fat mass, BMI, W, H, Glucose, Insulin, TC, TG, LDL-C, SBP, DBP | 6 months |
|  |  | CR | 83 | 58 ± 10 | 40.96 | Weight, Fat mass, BMI, W, H, Glucose, Insulin, TC, TG, LDL-C, SBP, DBP | 6 months |